|
Pat Deverka, MD, MS, MBE, is a research associate professor in the school of Pharmacy at UNC and a faculty member of the Institute for Pharmacogenomics and Individualized Therapy. From 2004-2007, she was a Fellow in the Center for Genome Ethics, Law and Policy at Duke’s Institute for Genome Sciences and Policy. Previously employed as a health services researcher in the pharmaceutical and managed care industries, she focused primarily on measuring the impact of new pharmaceuticals and drug benefit plan designs on clinical and economic outcomes. Patricia was Vice President of Scientific Affairs at Medco Health, where she developed strategies to help pharmacy benefit managers and payers evaluate advances in pharmacogenomics and plan for the responsible diffusion of personalized prescribing into the marketplace.
Her current research interests include the evaluation of the ethical and policy dimensions of introducing new genomic-based technologies (personalized medicine) into clinical practice, as well as the regulation of biobanks. Patricia earned her medical degree from the University of Pittsburgh School of Medicine, a master’s degree in Preventive Medicine from the University of Maryland and a master’s degree in bioethics from the University of Pennsylvania.
|